Concepedia
Statistics
Publications
4
Citations
144
H-Index
Active since
2024
Affiliations
Shenzhen University(Current)
Shenzhen University Health Science Center
University Town of Shenzhen
Shenzhen Institute for Drug Control
University of South China
Lulu Li is an author at Shenzhen University specializing in oncology, immune checkpoint inhibitors, and molecular oncology.
Publications per year
2024–2024
Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer
Wenjun Huang, Qingyun Zhu, Zhichao Shi et al. · Cell Death Discovery · 2024 · 55 citations · Full text
Life Sciences, Immunology, Oncology +17
Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer
Qingyun Zhu, Qiuzi Dai, Lei Zhao et al. · Cell Death and Disease · 2024 · 38 citations · Full text
Medicine, Oncology, Pharmacology +17
Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy
Zhanbo Yang, Bizhu Chu, Yao Tu et al. · Pharmacological Research · 2024 · 32 citations · Full text
Bifunctional HDAC and DNMT inhibitor induces viral mimicry activates the innate immune response in triple-negative breast cancer
Weiwen Fan, Wenkai Li, Lulu Li et al. · European Journal of Pharmaceutical Sciences · 2024 · 19 citations · Full text
Medicine, Molecular Biology, Oncology +17
1–4 of 4